Abstract
BACKGROUND
The aim of this study was to develop and characterize standardized in vitro three-dimensional organotypic models of human junctional epithelium (JE) and sulcular epithelium (SE).
METHODS
Organotypic models were constructed by growing human normal gingival keratinocytes on top of collagen matrices populated with gingival fibroblasts (GF) or periodontal ligament fibroblasts (PLF). Tissues obtained were harvested at different time points and assessed for epithelial morphology, proliferation (Ki67), expression of JE-specific markers (ODAM and FDC-SP), cytokeratins (CK), transglutaminase, filaggrin, and basement membrane proteins (collagen IV and laminin1).
RESULTS
The epithelial component in 3- and 5-day organotypics showed limited differentiation and expressed Ki-67, ODAM, FDC-SP, CK 8, 13, 16, 19, and transglutaminase in a similar fashion to control JE samples. PLF supported better than GF expression of CK19 and suprabasal proliferation, although statistically significant only at day 5. Basement membrane proteins started to be deposited only from day 5. The rate of proliferating cells as well as the percentage of CK19-expressing cells decreased significantly in 7- and 9-day cultures. Day 7 organotypics presented higher number of epithelial cell layers, proliferating cells in suprabasal layers, and CK expression pattern similar to SE.
CONCLUSION
Both time in culture and fibroblast type had impact on epithelial phenotype. Five-day cultures with PLF are suggested as JE models, 7-day cultures with PLF or GF as SE models, while 9-day cultures with GF as gingival epithelium (GE) models. Such standard, reproducible models represent useful tools to study periodontal bacteria–host interactions in vitro.
Keywords: cytokeratins, differentiation, oral epithelia, organotypic, periodontal tissue
Introduction
Anatomically, gingival epithelium consists of oral gingival epithelium (GE), sulcular epithelium (SE), and junctional epithelium (JE) 1. The JE mediates the attachment of gingiva to the teeth through hemidesmosomes and the internal basal lamina with a unique basement membrane (BM) composition, while being attached to the connective tissue by the external basal lamina, containing many of the components of gingival basement membrane, including collagen IV 2. JE is a multilayered epithelium with permeable structure, high turnover (the highest among oral tissues), and limited differentiation, lacking keratinization. The SE makes the transition between JE and GE and lines the gingival sulcus. The distinctive structure and function of these epithelia are also reflected by the presence of specific proteins and differentiation markers. The odontogenic ameloblast-associated (ODAM) protein 3 and follicular dendritic cell-secreted (FDC-SP) protein 4 have been recently identified as having a specific expression to JE. The expression of keratinocyte differentiation markers such as cytokeratins (CK), filaggrin, and transglutaminase 5–7 makes also a clear delimitation between these epithelia. CK are major structural proteins expressed by epithelial cells according with the stage of differentiation and the origin of the epithelium 8–10. Transglutaminase (TG) is an enzyme that plays an important role in the late differentiation of the mature keratinocyte 11, being expressed in oral tissues in spinous layers both in orthokeratinized (such as the hard palate) and non-keratinized (buccal mucosa) epithelia 12. Filaggrin is also a late marker of keratinization, present in vivo in orthokeratinized and parakeratinized areas of human oral epithelium 13,14.
The native GE was reported to express the cytokeratins 5 and 14 and occasionally CK19 in the basal layers. In the suprabasal layers, the native GE expresses CK 1/10 (characteristic for keratinized squamous stratified epithelia), CK 6/16 (markers of hyperproliferation), as well as transglutaminase and filaggrin 7,13. JE has a unique phenotype, expressing cytokeratins specific for simple epithelia, such as CK 7, 8, 18, and 19 and for basal layers (CK 5 and 14), but also for non-keratinizing stratified epithelia, CK 13 and 16 5,15–17. While expression of CK 8/18 in JE may vary in frequency and intensity 5,7, the presence of CK 19 is regarded as a consistent marker for JE 16,17. The SE is a non-keratinizing stratified squamous tissue lacking stratum granulosum, found in GE 18. SE displays higher number of cell layers and better differentiated than JE, but expresses CK 19, the marker of JE, to a lesser degree. The proliferation rate in SE is higher than in GE 19.
The SE and JE are continuously challenged by bacterial biofilm from subgingival plaque; thus, they represent crucial sites with respect to initiation and development of periodontal diseases. Bacteria can invade through epithelial layers, elaborate bacterial byproducts and induce a local immune response, which can lead to breakdown of periodontal tissues. Hence, in vitro studies investigating host–bacteria interactions mimicking periodontal conditions have more relevance to be performed by using culture models resembling JE or SE 20. In vivo, the phenotype of the epithelium and implicitly the CK expression are influenced by the interactions with the sub-epithelial mesenchyme and eventual pathological changes (such as inflammation, dysplasia or malignant transformation of epithelia) 21–23. Similarly, when oral tissues are reconstructed in vitro, as multilayered three-dimensional (3D) organotypic (OT) culture models, the CK expression of the epithelial component is strongly influenced by the type of underlying matrix and the origin of fibroblasts contained in it 8,24,25.
The aim of this study was thus to develop and characterize standardized models of junctional and sulcular human epithelium that can be used to study periodontal bacteria–host tissue interactions. For this purpose, the morphology, cell proliferation, and CK profile of OT models reconstructed with primary human gingival keratinocytes on top of fibroblast-populated collagen biomatrices were assessed at different stages of growth. The impact of two different types of oral fibroblasts (periodontal vs. gingival) on epithelial differentiation and phenotype was evaluated. We have investigated which combination of type of fibroblasts and growth stage may result in a model that resembles best the junctional or sulcular epithelium. Such model may represent a functional tool for studying periodontal bacteria–host tissue interactions in vitro.
Materials and methods
Materials
Dulbecco's modified Eagle's medium (DMEM) was acquired from Sigma (St Louis, MO, USA). Serum-free keratinocyte medium (KSFM), human recombinant epidermal growth factor (EGF), bovine pituitary extract (BPE), fetal bovine serum (FBS), l-glutamine, penicillin, streptomycin, and amphotericin B were acquired from GibcoBRL (Grand Island, NY, USA). Cell culture flasks and plates were from Nunc (Napervile, IL, USA), and center-well organ culture dishes were from BD Biosciences (San Jose, CA, USA). The Envision+ system used in immunohistochemistry was from DAKO (Glostrup, Denmark). Antibodies used in this study are presented in Table 1.
Table 1.
Antibody | Type | Clone/number | Titration | Source |
---|---|---|---|---|
FDC-SP | Rabbit polyclonal | Anti-C4 or f7 HPA014326 | 1:80 | Sigma, St Louis, MO, USA |
ODAM | Rabbit polyclonal | HPA036543 | 1:10 | Sigma, St Louis, MO, USA |
CK 8 | mouse monoclonal | Supernatant | 1:5 | CRUK |
CK 10 | IgG-1 | – | 1:50 | DAKO A/S, Glostrup, Denmark |
CK 13 | IgG-1 | KS-1A3 | 1:50 | Novocastra |
CK 16 | Mouse monoclonal | Supernatant | 1:5 | CRUK |
CK 19 | Mouse monoclonal | Supernatant | 1:5 | CRUK |
Ki-67 | IgG-1 | MIB-1 | 1:25 | DAKO A/S, Glostrup, Denmark |
Filaggrin | IgG-1 | 15CID | 1:50 | Monosan |
TG | Rabbit polyclonal | pab0061 | 1:250 | Covalab-UK |
Collagen IV | IgG-1 | CIV 22 | 1:50 | DAKO A/S, Glostrup, Denmark |
Laminin-1 | IgG-2a | 4C7 | 1:1200 | DAKO A/S, Glostrup, Denmark |
CRUK, Cancer Research United Kingdom (Abs were a kind gift from Prof. I. C. Mackenzie, Institute for Cell and Molecular Science, London, UK).
Cell isolation and culture
Clinically healthy adult volunteers (n = 12) undergoing surgical removal of wisdom teeth were informed about the purpose of study and gave their written consent regarding sample collection. The study was approved by the Regional Committee for Medical Ethics in Research. A total of 12 samples of gingival mucosa showing no sign of clinical inflammation at collection time and seven wisdom teeth were used to generate primary keratinocytes and fibroblasts. Samples of native normal tissues of JE (n = 6), SE (n = 6), and GE (n = 7) served as controls for in vivo expression patterns of the investigated proteins. The normal/native tissues and specimens were previously collected with ethical clearance by one of the co-authors for characterization of periodontal tissue. Normal human gingival mucosa, skin, breast, tonsil, and prostate specimens served as positive controls for protein detection. Gingival epithelial cells (GECs) were isolated as previously described through a combination of enzymatic digestion and mechanical separation of cells and cultured in serum-free media (KSFM) supplemented with 1 ng/ml EGF, 25 μg/ml BPE, 20 μg/ml l-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, and 0.25 μg/ml amphotericin B 26. We have previously published the protocol for the isolation and characterization of gingival fibroblasts (GF) and periodontal ligament fibroblasts (PLF) based on alkaline phosphatase (ALP) expression as marker of differentiation 27. Briefly, fibroblast cells were cultured in DMEM supplemented with 10% FBS, 20 μg/ml l-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, and 0.25 μg/ml amphotericin. The cells used were GECs in their 1st to 3rd passage and GFs or PLFs in their 2nd to 5th passage. All cultures including the organotypic models were kept in a humidified atmosphere at 37°C and supplemented with 5% CO2.
Construction and harvesting of OT tissue models
In our laboratory, the construction of an OT model of oral mucosa that reaches its maturity at day 9 of development after adding the keratinocytes on top of fibroblast-populated biomatrices has been well established and previously described 28. The multilayered epithelium was elaborated using GECs grown on top of collagen matrices populated with oral fibroblasts. In this study, 250 000 fibroblast cells, either GF or PLF (in some cases matched from the same donor), were used for each collagen matrix. A number of 500 000 GECs in 1-ml KSFM were seeded on top of each collagen matrix the following day, considered day 1. The further handling of OTs was carried out as previously described 28, and the tissues being placed on grids and lifted on the air-liquid interface. The harvesting of the OTs was performed at different time intervals of their development: at day 3, 5, 7, and 9. The OT tissue samples further investigated here were formalin-fixed and paraffin-embedded. Six different experiments with GF/ PLF were carried out.
Tissue preparation, staining, and analysis
Sections of 5 μm thickness from formalin-fixed OT tissues were cut and stained with hematoxylin–eosin (HE) or used for immunohistochemistry (IHC). IHC staining was carried out as routinely in our laboratory and previously described. Information on the primary antibodies used in the study is detailed in Table 1. All primary antibodies were applied for 60 min. TE buffer (10 mM Tris, 0.1 mM EDTA, pH 9) was used for all markers except for TG (where citrate buffer pH 6 was used) and 60-min incubation. As positive controls were used tissue samples of breast epithelium and prostate for markers CK 8 and 19; gingival mucosa, skin, and tonsil tissue for ODAM, FDC-SP, collagen IV and laminin-1; buccal mucosa for CK 13; and palate epithelium for CK 10, CK 16, transglutaminase and filaggrin. Specimens incubated with antibody diluent only (DAKO) or isotype-matched antibody (DAKO) instead of primary antibody were used as a negative control.
The HE stained tissues were evaluated under a light microscope (Leica DMLM, GmbH, Munster, Germany). Epithelial cell layers were counted and evaluated morphologically for epithelial growth, degree of keratinization, and differentiation pattern and compared with control tissues. Exfoliated cells were not included in the counting of cell layers, and the tissue ends (margins) were also excluded 29,30. Each tissue was examined with a 40× objective, and images of three to six fields separated by 334 μm distance were taken with a camera connected to a computer. By use of Olympus Soft-DP 5.0 software package (Soft Imaging System GmbH), histomorphometric and immunohistochemical analyses were performed on each image, which had a horizontal width of 334 μm at this magnification.
For quantification, the Ki-67- and CK19-expressing cells and also the negative cells were counted manually at 400-fold magnification. The Ki-67 immunopositive cells were counted in all layers in sections for OTs harvested at day 3, and starting from day 5 up, they were counted separately in basal/parabasal and suprabasal regions of the epithelial component. The delimitation of layers in basal and suprabasal regions was made according to morphology of the cells in the respective layers (higher ratio nucleus/cytoplasm, vertical or angular orientation of cell axis on the basal membrane). Cell proliferation was calculated as percentage of Ki-67-positive cells from all cells of the basal layers and/or the total number of Ki-67 expressing nuclei per 334 μm length of the epithelial–connective tissue equivalent interface. The number of proliferating nuclei in suprabasal layers was also registered. The CK 19-expressing cells were calculated as the percentage of positive cells within all cell layers from day 3 to day 9.
The in vitro constructed models were compared at different development stages or related to the type of fibroblasts used in the matrix and also with the control tissues.
Statistical analysis and data presentation
Each individual experiment was run in duplicate or triplicate. The mean of CK 19 or Ki-67-expressing cells was calculated per experiment, and paired t-test was performed to compare the GF vs. PLF tissues within the same experiment at each stage of differentiation. Data were analyzed for other parameters using analysis of variance (ANOVA) with Bonferroni multiple comparisons using SPSS version 13 statistical software package (SPSS Inc, Chicago, IL, USA). P-values <0.05 were considered significant.
Results
Histomorphometric evaluation of the epithelial compartment in reconstructed tissues
At day 3 of development, the epithelium was comprised of 1–4 cell layers (37.73 ± 10.87 μm thickness, mean, and standard deviation) without any sign of differentiation in all OTs. At day 5, the epithelial component displayed 3–5 cell layers (49.79 ± 11.50 μm) and very little differentiation, as only one superficial cell layer had a more flatten morphology and could be considered as suprabasal. For both day 3 and day 5 OTs, there was no noticeable difference between OTs constructed using GF or PLF, as assessed by histological analysis of HE stained tissues (Fig. 1).
At day 7, the OT models had an epithelial component of 9–13 layers (130.93 ± 29.28 μm), increasing to 11–16 layers at day 9 (190.83 ± 16.78 μm). In all 7- and 9-day OT models, the differentiation was visible and the presence of the spinous layers could be noticed. No significant difference in the thickness could be observed between OTs constructed with GF or PLF at days 7 and 9 either. Variations from batch to batch could be observed regarding size of the cells, total number of layers or degree of differentiation. However, some of the tissues constructed with GF showed a well-differentiated superficial cell layer compared with those constructed with PLF at day 9, but such differences were not found consistently in all batches.
Distribution and quantification of proliferating cells (Ki-67)
In vivo, the cell proliferation rate is an important feature that differentiates JE, having the highest cell turnover among all types of periodontal and oral tissues. Therefore, we have quantified the Ki-67-expressing cells in the reconstructed OT models for the purpose of comparison. The distribution and number of Ki-67-positive cells varied in culture with the time allowed for development and differentiation. Day 3 and day 5 OT cultures showed proliferating cells distributed in all cell layers, similarly with the situation encountered in JE in vivo. In these OTs, we found significantly higher proliferation rate (P < 0.001), in cultures both with GF and with PLF, compared with those harvested at later time points (day 7 and 9) (Fig. 2A). The type of fibroblasts was not found to influence significantly (P = 0.38) the proliferation rate within the basal and parabasal layers of organotypic models. Interestingly, significant more Ki-67-positive cells were detected at day 5 in suprabasal layers (P = 0.018, paired t-test) in tissues with PLF (2.34 ± 0.39, mean and standard error) than in those with GF (1.28 ± 0.43). At day 7, fewer Ki-67-expressing nuclei were counted in suprabasal layers, (1.03 ± 0.51 in GF OTs and 1.13 ± 0.59 in those with PLF, respectively; Fig. 2B). At day 9, no Ki-67-expressing cells were present in suprabasal layers.
Expression of specific markers of JE
The JE-specific markers ODAM and FDC-SP were detected in all epithelial layers of day 3 and day 5 cultures. Both GF and PLF supported the expression of these two markers in the suprajacent epithelium, but PLF stronger than GF (Fig. 3). The expression of ODAM was maintained at day 7 and 9 in basal cell layer only, while FDC-SP was not detected in OT models of day 7 and 9. ODAM was expressed in all layers of native JE and SE, but in SE the staining was stronger toward the basal and superficial layers. In native GE, expression of ODAM was maintained in the basal layer with only few scattered positive cells in the superficial layers. In the native JE, 50–75% of cells of all layers stained positive for FDC-SP. The staining faded toward SE and GE. Nevertheless, in 50% of the cases examined, the expression of FDC-SP was maintained in the spinous layer of GE, although much less intense than in JE.
Expression pattern of differentiation markers in reconstructed and control tissues
A summary of expression of the differentiation markers, both in reconstructed tissues and in controls, is presented in Table 2. The CK 13, 16, and 19 were consistently found expressed in the epithelium of all OT cultures, constructed either with GF or with PLF. In OTs, the marker for stratified squamous non-keratinized epithelia CK 13 was present throughout all epithelial layers at day 3 but more variable at day 5, becoming stronger in upper layers. At days 7 and 9, the expression of CK 13 became polarized, as all cells of suprabasal layers stained strongly for this marker, while cells in basal layers were positive in a variable proportion from a few scattered cells to about 50% positive. Slight variations were observed from batch to batch or even within the same tissue model. The CK 13 staining in JE control tissue was positive in all layers, in a proportion slightly varying between samples, from 85% to 100%. The SE control tissues expressed CK 13 only in suprabasal layers, and the staining was gradually lost toward GE, where this marker was nearly absent.
Table 2.
In organotypicsa | Control SE | |||||||
---|---|---|---|---|---|---|---|---|
Marker | d3 | d5 | d7 | d9 | Control JE | AM | GM | Control GE |
FDC-SP | + | + | − | − | + | +/− | +/− | +/− |
ODAM | + | + | +/− | +/− | + | + | + | +/− |
CK 8 | + | − | − | − | − | − | − | − |
CK 10 | − | − | +/− | + | − | − | + | + |
CK 13 | + | + | + | + | + | + | − | − |
CK 16 | + | + | + | + | +/− | +/− | − | + |
CK 19 | + | + | + | + | + | + | + | + |
Filaggrin | − | − | − | − | − | − | − | + |
TG | + | + | + | + | + | + | + | + |
Collagen IV | − | +/− | + | + | + | + | + | + |
Laminin-1 | − | +/− | + | + | + | + | + | + |
The description of the immunostaining refers to both GF and PLF – constructed organotypics if not otherwise mentioned. AM, apical margin, GM, gingival margin.
At day 3, the OTs expressed CK 16 in the cells of the upper layers and sparsely in the basal cell layer, where only a few positive cells were found, matching with the expression of this marker determined in control tissues. In JE, CK 16 was found positive only in half of the samples where was expressed by approximately 30% of cells. OT tissues constructed with both GF with PLF from day 5 to day 9 stained positive for CK 16 only in the suprabasal layers. SE control tissues displayed CK 16 immunopositive cells in the spinous layer and sparsely in basal cells and the staining faded or disappeared toward JE. In GE control tissues, we have found CK 16-positive cells in parabasal and suprabasal cells, much stronger stained in the spinous layer.
CK 19 was expressed in all OT reconstructed tissues, in all cell layers, stronger at 3 and 5 days of culture and slightly fading at days 7 and 9, especially in OTs constructed with GF (Fig. 4). The percentage of CK 19-positive cells decreased gradually with the time allowed for maturation of the tissue cultures. In GF tissues, from 70.3 ± 2.83% (mean and standard error) CK19-positive cells determined at day 3 and 67.91 ± 2.03% at day 5, the percentage decreased further to 53.17 ± 2.65% at day 7 and 31.24 ± 4.97% at day 9. The length of time the in vitro reconstructed tissues were allowed to develop in culture before harvesting and analyzing was found statistically significant by ANOVA test for repeated measurements (P = 0.003) as having the main effect for expression of this marker in OT culture. The OTs constructed with PLF expressed CK 19 in a higher percentage than those with GF, as 76.95 ± 0.87% of the cells at day 3 stained positively and 72.81 ± 2.72% at day 5, respectively. The proportion of CK 19-expressing cells decreased further, reaching 56.29 ± 2.04% at day 7 and 35.45 ± 5.44% at day 9 in PLF organotypics. Although the expression of CK 19 was maintained higher in PLF than in GF organotypics throughout all development stages, when these groups were compared by use of paired t-test, statistical significance was found only at day 5 (P = 0.047). In vivo, CK 19 was expressed intensely in all samples in all layers of JE, while in control SE the expression changed from intensely positive cells toward apical margin, until almost disappearing toward the coronal region. In GE, there were very few CK 19-positive cells, scattered in the basal layers in rete ridges (Fig. 4).
The marker for simple epithelia CK 8 was weakly positive in few of our OT cultures constructed with both GF and PLF, only at day 3 and not in cultures at day 5 or older. The control tissues did not stain positive for CK 8 either, but few single cells in the basal layers of rete ridges in GE were observed, as for CK 19. The positive control (prostate tissue) showed intense staining for CK 8.
In OT cultures grown to day 3 and 5, the marker for stratified keratinized epithelia CK 10 was absent. In samples harvested at day 7, CK10-positive cells were found sparsely in spinous layers, in approximately 20% of the samples, in OT tissues constructed with both GF and PLF. The expression of CK 10 OTs was much stronger at day 9, in spinous and superficial layers, in cultures with both types of fibroblasts. This pattern was observed also in control tissues: absence of CK 10 in JE, very rare positive cells in SE (more toward gingival margin), and strong expression in spinous and superficial layers of GE.
Transglutaminase stabilizes the epithelium by cross-linking constituent proteins; thus, it has been used as a marker for epidermal cell maturation. It was expressed in all layers of day 3 cultures, constructed with either GF or PLF, while in days 5, 7, and 9 it was present mainly in the upper layers and seemed stronger in OT with GF. In control JE, transglutaminase was found positive in the upper part of the tissue. In SE, the staining faded toward apical margin, but it was stronger in spinous layers toward gingival margin. Transglutaminase was expressed in spinous layers of GE control tissues.
The other marker of late keratinisation, filaggrin, was not found positive in any of OT cultures. This marker lacked as well from JE and SE control samples, but was found positive in upper layers of GE control tissues.
Collagen IV, characteristic for basal membranes and external basal lamina in JE, was not detected in OTs of day 3. At day 5, collagen IV was found sparsely deposited in OTs constructed with both GF and PLF (Fig. 5). The deposition of collagen IV was still weak and irregular at day 7, but was observed as a continuous line in OTs grown till day 9. Laminin-1, another protein characteristic for basal membranes, was expressed by the epithelial cells nearby epithelium-collagen matrix interface in all OTs, but its deposition extracellularly was not detected till day 5, when it was sparce and discontinuous in OTs with both GF and PLF (Fig. 5). The deposition of laminin-1 became more obvious at day 7 and further more developed at day 9, when it was visible as a continuous line in OTs constructed with both type of fibroblasts.
Concluding, based on the analyses of tissue morphology and differentiation, correlated with the expression pattern of different markers, and the decline of proliferating cells in the basal layers, the OT cultures could be grouped in ‘early’ (day 3 and 5) and ‘late’ (day 7 and 9) culture models. The ‘early’ OT cultures had low number of epithelial layers, none, or very little differentiation (one suprabasal layer at day 5) and high number of proliferating cells distributed in all cell layers. The specific markers (FDC-SP and ODAM), the CKs (CK 19, 13, 16, and 8), and transglutaminase normally expressed by native JE 5,7,15,17 were also determined in our ‘early’ OT models (especially in those constructed with PLF) as having a distribution pattern similar with the one encountered in vivo. The markers CK 10 and filaggrin normally lacking from JE 7,13,16,24 were also lacking from day 3 and 5 OT models. Deposition of basement membrane proteins was detected only from day 5 OTs.
Discussion
In the present study that aimed to develop and characterize in vitro models for periodontal tissue, we found that depending on the time allowed for the model to mature, we can develop models that resemble junctional, sulcular, or gingival epithelium by using gingival keratinocytes and periodontal and gingival fibroblasts.
Based on these findings, we suggest that the OT tissues grown for 5 days could serve as in vitro JE models. Particularly, the OTs grown with PLF showed a better preservation of the JE phenotype, reflected by a stronger expression of specific markers FDC-SP and ODAM, and higher percentage of CK 19-positive cells and proliferating cells in the suprabasal cell layers (Fig. 4). Although these models lack the internal basal lamina, they show some deposition of components of the external basal lamina (collagen IV and laminin 1). We propose that day 7 OT cultures could be taken in consideration as a model for SE, because of a higher number of cell layers, limited differentiation, presence of proliferating cells in suprabasal layers, and the expression pattern of different CKs and basement membrane proteins similar to the SE. The OT model containing GF matured to day 9 may be used as culture model for GE, as we have already indicated in a previous study 31.
Both the time in culture and type of fibroblasts influenced the tissue morphology, proliferation, and differentiation, but only time in culture had a significant impact on expression of CK 19 in our OT models. Our results are in agreement with those of Locke et al. 24 who reported that the type of fibroblasts used in the connective tissue equivalent influenced the CK expression in the epithelial component, but did not induce a complete change of the phenotype. However, they reported a markedly less growth of the epithelial component and weaker expression of CK 10 in the OT cultures engineered with PLF, compared with those with GF, having more cell layers and stronger CK 10 expression. In our work, we have observed higher differentiation in mature (day 9) OTs constructed with GF than in those with PLF; but the variations in epithelial thickness were not found significant at any time point (data not shown). These differences might be explained by different culture conditions, for example, time allowed for maturation, different culture medium, and different number of fibroblasts used in these two studies. While the study of Locke et al. investigates the tissues at one time point only, we have looked at different steps of development. In addition, we present here a feasible model of JE that can be obtained from GECs, which are easier to obtain and grow in culture in comparison with JE cells, as suggested by Locke et al. The novelty of our study is that by using the same cell type, namely GECs, one can build models of JE, SE, and GE by modulating the time in culture instead of using cells with originally different phenotype. Thus, the use of GECs instead of JE cells might present significant logistic advantages for constructing models for use as biological tools in experimental setting.
We have shown here that CK 19 was positive in all OT tissues up till day 9, even if these were constructed with GF. This differentiation marker is distinctive for JE but is sparsely expressed also in GE, and it appears to be increased in periodontitis 21,23,32,33. It has been shown that when cultured in vitro, cells isolated from GE were also found to express CK19, similarly with those isolated from JE 34. Gain of CK 19 in the gingival epithelial cells grown in culture both in colonies (monolayers) and in multilayered OT models was reported also by other studies 24,35. These studies did also point out to a slight change in the phenotype of gingival epithelial cells cultured in vitro, expressing markers of differentiation such as CK 1, 10, and 13 less intensely than in vivo and at the same time ‘gain’ or increase in intensity of the expression of cytokeratins characteristic for simple epithelia, CK 8/18 and 19, and for high proliferating tissues (CK 6/16). We also report here a stronger staining for CK 16 and the presence of CK 8 only in day 3 reconstructed tissues, compared with in vivo samples, where these markers were found scarce or absent. In conclusion, we agree with the above-mentioned studies that expression of differentiation markers in reconstructed culture models is close to the in vivo pattern, but not identical.
However, in the present study, we show a steady decline in time in expression of ODAM, FDC-SP and in the number of CK19-positive cells in OT cultures and determined that time in culture had a significant impact on expression of these markers. This finding indicates once more that 3D organotypic models are more appropriate experimental models and closer to the in vivo situation than 2D culture models. The development of such serial models is justified by the continuous and increasing interest of studying interactions between oral bacteria, including putative periodontal pathogens, and human oral tissues 31,36–40.
In our study, a higher expression of ODAM, FDC-SP, and CK 19 in the epithelial compartment was at all time points better supported by PLF than GF, although the type of the fibroblasts used in the connective tissue equivalent became statistically significant for expression of CK19 just at one time point, at day 5.
Of note is that at the same development point (day 5), the presence of PLF in the matrix influenced significantly the distribution pattern of the proliferation cells in the epithelium, PLF supporting suprabasal proliferation.
In conclusion, this study identifies certain culture conditions (time points and type of fibroblasts) that can be reproducibly used to develop standardized (serum free) models of human junctional or sulcular epithelium. Based on the characterization of the tissues we made, we suggest the use of the model with PLF at day 5 as a JE model for bacterial–host cell interactions. As for SE model, we consider appropriate the OT cultures constructed with either PLF or GF grown to day 7; and those with GF at/after day 9 as suitable for a gingival model. Such models may constitute a very useful working tool in investigating the mechanisms involved in periodontium breakdown in periodontal disease, especially in host tissue – bacterial interaction studies.
Acknowledgments
We acknowledge Evelyn Neppelberg from Institute for Clinical Odontology, University of Bergen, Norway, for tissue sample collection. Special thanks to Gunnvor Øijordsbakken, Edith Marianne Fick and Øyunn Nielsen from The Gade Institute, University of Bergen, Norway for technical help, especially with immunohistochemistry. This study was partially supported by a Colgate-Palmolive scholarship (GDW).
Conflict of interest
The authors report no conflicts of interest related to this study.
References
- 1.Schroeder HE, Listgarten MA. The gingival tissues: the architecture of periodontal protection. Periodontol 2000. 1997;13:91–120. doi: 10.1111/j.1600-0757.1997.tb00097.x. [DOI] [PubMed] [Google Scholar]
- 2.Oksonen J, Sorokin LM, Virtanen LM, et al. The junctional epithelium around murine teeth differs from gingival epithelium in its basement membrane composition. J Dent Res. 2001;80:2093–7. doi: 10.1177/00220345010800121401. [DOI] [PubMed] [Google Scholar]
- 3.Nishio C, Wazen R, Kuroda S, et al. Expression pattern of odontogenic ameloblast-associated and amelotin during formation and regeneration of the junctional epithelium. Eur Cell Mater. 2010;20:393–402. doi: 10.22203/ecm.v020a32. [DOI] [PubMed] [Google Scholar]
- 4.Oshiro A, Iseki S, Miyauchi M, et al. Lipopolysaccharide induces rapid loss of follicular dendritic cell-secreted protein in the junctional epithelium. J Periodontal Res. 2012 doi: 10.1111/j.1600-0765.2012.01482.x. [Epub ahead of print] [DOI] [PubMed] [Google Scholar]
- 5.Bosshardt DD, Lang NP. The junctional epithelium: from health to disease. J Dent Res. 2005;84:9–20. doi: 10.1177/154405910508400102. [DOI] [PubMed] [Google Scholar]
- 6.Juhl M, Reibel J, Stoltze K. Immunohistochemical distribution of keratin proteins in clinically healthy human gingival epithelia. Scand J Dent Res. 1989;97:159–70. doi: 10.1111/j.1600-0722.1989.tb01445.x. [DOI] [PubMed] [Google Scholar]
- 7.Mackenzie IC, Rittman G, Gao Z, et al. Patterns of cytokeratin expression in human gingival epithelia. J Periodontal Res. 1991;26:468–78. doi: 10.1111/j.1600-0765.1991.tb01797.x. [DOI] [PubMed] [Google Scholar]
- 8.Gosselin F, Magloire H, Joffre A, et al. Cytokeratins as molecular markers in the evaluation of the precise differentiation stage of human gingival epithelium reconstituted in vitro. Arch Oral Biol. 1990;35(Suppl):217S–21S. doi: 10.1016/0003-9969(90)90162-4. [DOI] [PubMed] [Google Scholar]
- 9.Ouhayoun JP, Gosselin F, Forest N, et al. Cytokeratin patterns of human oral epithelia: differences in cytokeratin synthesis in gingival epithelium and the adjacent alveolar mucosa. Differentiation. 1985;30:123–9. doi: 10.1111/j.1432-0436.1985.tb00523.x. [DOI] [PubMed] [Google Scholar]
- 10.Hatakeyama S, Yaegashi T, Oikawa Y, et al. Expression pattern of adhesion molecules in junctional epithelium differs from that in other gingival epithelia. J Periodontal Res. 2006;41:322–8. doi: 10.1111/j.1600-0765.2006.00875.x. [DOI] [PubMed] [Google Scholar]
- 11.Thacher SM, Rice RH. Keratinocyte-specific transglutaminase of cultured human epidermal cells: relation to cross-linked envelope formation and terminal differentiation. Cell. 1985;40:685–95. doi: 10.1016/0092-8674(85)90217-x. [DOI] [PubMed] [Google Scholar]
- 12.Ta BM, Gallagher GT, Chakravarty R, et al. Keratinocyte transglutaminase in human skin and oral mucosa: cytoplasmic localization and uncoupling of differentiation markers. J Cell Sci. 1990;95:631–8. doi: 10.1242/jcs.95.4.631. [DOI] [PubMed] [Google Scholar]
- 13.Presland RB, Dale BA. Epithelial structural proteins of the skin and oral cavity: function in health and disease. Crit Rev Oral Biol Med. 2000;11:383–408. doi: 10.1177/10454411000110040101. [DOI] [PubMed] [Google Scholar]
- 14.Smith SA, Dale BA. Immunologic localization of filaggrin in human oral epithelia and correlation with keratinization. J Invest Dermatol. 1986;86:168–72. doi: 10.1111/1523-1747.ep12284213. [DOI] [PubMed] [Google Scholar]
- 15.Pollanen MT, Salonen JI, Uitto VJ. Structure and function of the tooth-epithelial interface in health and disease. Periodontol 2000. 2003;31:12–31. doi: 10.1034/j.1600-0757.2003.03102.x. [DOI] [PubMed] [Google Scholar]
- 16.Pritlove-Carson S, Charlesworth S, Morgan PR, et al. Cytokeratin phenotypes at the dento-gingival junction in relative health and inflammation, in smokers and nonsmokers. Oral Dis. 1997;3:19–24. doi: 10.1111/j.1601-0825.1997.tb00004.x. [DOI] [PubMed] [Google Scholar]
- 17.Shimono M, Ishikawa T, Enokiya Y, et al. Biological characteristics of the junctional epithelium. J Electron Microsc (Tokyo) 2003;52:627–39. doi: 10.1093/jmicro/52.6.627. [DOI] [PubMed] [Google Scholar]
- 18.Garant PR. Oral Cells and Tissues. In: Arinne Dickson., editor. 1st edn. Canada: Quintessence Publishing Co, Inc; 2003. pp. 126–7. [Google Scholar]
- 19.Artese L, Piattelli A, De Gouveia Cardoso LA, et al. Immunoexpression of angiogenesis, nitric oxide synthase, and proliferation markers in gingival samples of patients with aggressive and chronic periodontitis. J Periodontol. 2010;81:718–26. doi: 10.1902/jop.2010.090524. [DOI] [PubMed] [Google Scholar]
- 20.Tribble GD, Lamont RJ. Bacterial invasion of epithelial cells and spreading in periodontal tissue. Periodontol 2000. 2010;52:68–83. doi: 10.1111/j.1600-0757.2009.00323.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Bosch FX, Ouhayoun JP, Bader BL, et al. Extensive changes in cytokeratin expression patterns in pathologically affected human gingiva. Virchows Arch B Cell Pathol Incl Mol Pathol. 1989;58:59–77. doi: 10.1007/BF02890059. [DOI] [PubMed] [Google Scholar]
- 22.Moll R, Divo M, Langbein L. The human keratins: biology and pathology. Histochem Cell Biol. 2008;129:705–33. doi: 10.1007/s00418-008-0435-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Ouhayoun JP, Goffaux JC, Sawaf MH, et al. Changes in cytokeratin expression in gingiva during inflammation. J Periodontal Res. 1990;25:283–92. doi: 10.1111/j.1600-0765.1990.tb00917.x. [DOI] [PubMed] [Google Scholar]
- 24.Locke M, Hyland PL, Irwin CR, et al. Modulation of gingival epithelial phenotypes by interactions with regionally defined populations of fibroblasts. J Periodontal Res. 2008;43:279–89. doi: 10.1111/j.1600-0765.2007.01028.x. [DOI] [PubMed] [Google Scholar]
- 25.Costea DE, Loro LL, Dimba EA, et al. Crucial effects of fibroblasts and keratinocyte growth factor on morphogenesis of reconstituted human oral epithelium. J Invest Dermatol. 2003;121:1479–86. doi: 10.1111/j.1523-1747.2003.12616.x. [DOI] [PubMed] [Google Scholar]
- 26.Costea DE, Dimba EO, Loro LL. Proliferation and differentiation in organotypic serum free cultures of normal human oral mucosa. In: Varma AK, Kowalski LP, Herter NT, et al., editors. Delhi, Rio de Janeiro: Rajkamal Electric Press; 2002. pp. 108–13. 8th International Congress on Oral Cancer. [Google Scholar]
- 27.Dabija-Wolter G, Cimpan MR, Costea DE, et al. Fusobacterium nucleatum enters normal human oral fibroblasts in vitro. J Periodontol. 2009;80:1174–83. doi: 10.1902/jop.2009.090051. [DOI] [PubMed] [Google Scholar]
- 28.Costea DE, Dimba AO, Loro LL, et al. The phenotype of in vitro reconstituted normal human oral epithelium is essentially determined by culture medium. J Oral Pathol Med. 2005;34:247–52. doi: 10.1111/j.1600-0714.2005.00308.x. [DOI] [PubMed] [Google Scholar]
- 29.Lukandu OM, Neppelberg E, Vintermyr OK, et al. Khat alters the phenotype of in vitro-reconstructed human oral mucosa. J Dent Res. 2010;89:270–5. doi: 10.1177/0022034509354980. [DOI] [PubMed] [Google Scholar]
- 30.Neppelberg E, Costea DE, Vintermyr OK, et al. Dual effects of sodium lauryl sulphate on human oral epithelial structure. Exp Dermatol. 2007;16:574–9. doi: 10.1111/j.1600-0625.2007.00567.x. [DOI] [PubMed] [Google Scholar]
- 31.Dabija-Wolter G, Sapkota D, Cimpan MR, et al. Limited in-depth invasion of Fusobacterium nucleatum into in vitro reconstructed human gingiva. Arch Oral Biol. 2012;57:344–51. doi: 10.1016/j.archoralbio.2011.09.015. [DOI] [PubMed] [Google Scholar]
- 32.Mackenzie IC, Gao Z. Patterns of cytokeratin expression in the epithelia of inflamed human gingiva and periodontal pockets. J Periodontal Res. 1993;28:49–59. doi: 10.1111/j.1600-0765.1993.tb01050.x. [DOI] [PubMed] [Google Scholar]
- 33.Nagarakanti S, Ramya S, Babu P, et al. Differential expression of E-cadherin and cytokeratin 19 and net proliferative rate of gingival keratinocytes in oral epithelium in periodontal health and disease. J Periodontol. 2007;78:2197–202. doi: 10.1902/jop.2007.070070. [DOI] [PubMed] [Google Scholar]
- 34.Matsuyama T, Izumi Y, Sueda T. Culture and characterization of human junctional epithelial cells. J Periodontol. 1997;68:229–39. doi: 10.1902/jop.1997.68.3.229. [DOI] [PubMed] [Google Scholar]
- 35.Garzon I, Sanchez-Quevedo MC, Moreu G, et al. In vitro and in vivo cytokeratin patterns of expression in bioengineered human periodontal mucosa. J Periodontal Res. 2009;44:588–97. doi: 10.1111/j.1600-0765.2008.01159.x. [DOI] [PubMed] [Google Scholar]
- 36.Sandros J, Papapanou PN, Nannmark U, et al. Porphyromonas gingivalis invades human pocket epithelium in vitro. J Periodontal Res. 1994;29:62–9. doi: 10.1111/j.1600-0765.1994.tb01092.x. [DOI] [PubMed] [Google Scholar]
- 37.Papaioannou W, Van Steenberghe D, Cassiman JJ, et al. Adhesion of Porphyromonas gingivalis to cultured pocket epithelium: mono- and multi-layered. Clin Oral Invest. 2003;7:162–6. doi: 10.1007/s00784-003-0217-4. [DOI] [PubMed] [Google Scholar]
- 38.Gursoy UK, Pollanen M, Kononen E, et al. Biofilm formation enhances the oxygen tolerance and invasiveness of Fusobacterium nucleatum in an oral mucosa culture model. J Periodontol. 2010;81:1084–91. doi: 10.1902/jop.2010.090664. [DOI] [PubMed] [Google Scholar]
- 39.Andrian E, Grenier D, Rouabhia M. In vitro models of tissue penetration and destruction by Porphyromonas gingivalis. Infect Immun. 2004;72:4689–98. doi: 10.1128/IAI.72.8.4689-4698.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Andrian E, Mostefaoui Y, Rouabhia M, et al. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model. J Cell Physiol. 2007;211:56–62. doi: 10.1002/jcp.20894. [DOI] [PubMed] [Google Scholar]